 - selumetinibtherefore, patients who have already participated in this study and been taken selumetinib or any other MEKMitogen-activated protein kinase kinase or Mitogen-activated protein kinase MAPK Extracellular signal-regulated kinase ERK kinase 12 inhibitor in past 